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Control of Conination in Ophthalmic Solutions
Ophthalmic solutions should be capable of withstanding physical, chemical and biological changes that may make them less effective therapeutically. The pharmacist must formulate such preparations with attention to many factors, the most important of which are tonicity, pH, stability, viscosity and sterility. I shall consider the last factor in this communication. Sterilization An injured eye has less resistance to infection than the bloodstream, so that equally rigid precautions should be taken in preparing ophthalmic solutions as in preparing solutions for intravenous use. The United States National Formulary XI states that all solutions for surgical use should be sterile and prepared without a preservative because of danger of chemical damage to the inner structure of the eye.
It has frequently been shown that a significant proportion of used and unused ophthalmic solutions were contaminated with Ps. aeruginosa and that eye ointments are also liable to contamination (Hugill et al. 1960 , Ridley 1958 , Lehrfeld & Donnelly 1948 . There is now widespread agreement that ideally ophthalmic medicaments should be dispensed in a sterile condition (Riegelman et al. 1956 , Hugill et al. 1960 , Brown etal. 1964 ).
The United States Pharmacopeia, the United States National Formulary and the International Pharmacopoeia all specify sterility for ophthalmic solutions. The British Pharmaceutical Codex now also stipulates sterility.
Autoclaving in the final container is the method of choice because of the danger from pathogenic spore formers. With chemically preserved solutions germination on the cornea can apparently occur as a result of the elimination of the carryover activity of a wide range of antibacterial agents (Riegelman et al. 1956 ). It is, however, unlikely that pathogenic spores would germinate in the ophthalmic container in the presence of an antibacterial agent at room temperature. Gamma radiation has proved a useful sterilizing agent for some heat-labile ophthalmic preparations and may prove to have a wide application (Ogg 1963) . Current work in our School is proceeding along these lines.
Other methods of sterilization include bacterial filtration (e.g. Millipore filtration), steaming in the presence of an antimicrobial agent and aseptic mixing of materials sterilized in different ways. The BPC now suggests appropriate methods for each preparation.
Container
The container must not only protect the ophthalmic preparation from the external environment but it should not itself interact with the preparation. Glass dropper bottles in current use suffer from several disadvantages; these include a tendency for the glass to leach out alkali, the possibility of the rubber teat interacting with active ingredients and difficulty of autoclaving. A British Standard specification 1679 sets requirements to minimize these defects.
Plastic containers, which are not as inert as formally thought, pose very complex problems. Various types of plastic differ in chemical and physical properties including permeability to gases such as oxygen. Cost is also an important factor. It seems likely, however, that we are progressing towards a relatively small plastic 'squeeze-type' container made of a material such as nylon or Melinex. Single-dose units are generally to be preferred.
Preservation against Micro-organisms
There has recently been much discussion about the difficulties of preserving ophthalmic solutions against micro-organisms. The main problem is the exceptionally high resistance of Ps. aeruginosa to chemical antibacterial agents. This pathogen, which can be a dangerous contaminant (Rogers 1960 , Gould 1963 , is especially hazardous in ophthalmology . Some species of aerobacter are eye pathogens (Crompton et al. 1964 ) and the problem is further complicated by the existence of pathogenic strains of the spore formers Bacillus subtilis (Roemer 1901) and Clostridium welchii (Henkind & Fedukowicz 1963) .
Pseudomonads have been isolated from most naturally occurring waters (Rhodes 1957) . Ps. aeruginosa in particular has exceptionally simple requirements and will grow in many ophthalmic solutions. This organism has been shown to use the hydroxybenzoates as a sole source of carbon (Hugo & Foster 1964) . In addition, the temperature requirements for growth are wide. It is a virulent pathogen capable of causing severe ocular infections (Duke-Elder 1964) . Relatively small inocula of about 50-100 cells have been shown to produce infection in rabbits' eyes (Riegelman et al. 1956 , Crompton et al. 1962 . Fisher & Allen (1958) have shown that Ps. aeruginosa produces an enzyme which destroys the cornea by degradation of corneal collagen.
Ps. aeruginosa has consequently been recommended as the main reference organism when selecting chemical preservatives for ophthalmic solutions. An adequate preservative should also be effective against a wide range of Gram-positive and Gram-negative organisms.
Ps. aeruginosa has frequently been isolated from fluorescein drops (Dale et al. 1959) and work is in progress in our laboratory on the survival of this organism in 2% fluorescein solution (pH 9 2) at 21°C. We have found that an inoculum of washed cells in M/2 NaCl to give 106 cells/ml is sterilized in about a day. On the other hand an inoculum of 0-5 ml nutrient broth culture (twenty-four-hour) added to 100 ml fluorescein 2 % solution to give 106 cells/ml will in fact stay relatively constant for months. This evidence seems to support the case for sterile single units of this solution.
Preservation ofSolutions
The possibility of contamination from pathogenic organisms subsequent to sterilization makes it necessary to incorporate a suitable antibacterial agent when using multidose containers.
The capacity of small inocula of Ps. aeruginosa to cause infection, together with the neutralizing properties of the cornea towards antibacterial agents, indicates that these agents should be capable of maintaining sterility.
Much of the earlier work on preservatives is of limited value because of inadequate experimental procedures. Riegelman et al. (1956) quoted numerous papers which did not state the precautions taken to ensure the absence of bacteriostatic concentrations of preservative in subcultures when testing for recovery. They discussed the inadequacy of dilution techniques designed to inactivate preservatives and introduced in vivo procedures as well as in vitro tests involving chemical antagonists. They consistently found that organisms would produce infections, and could be recovered from the cornea while in vitro cultures were apparently negative. Subsequent improvement of the antagonist/recovery broth reduced the discrepancy. Kohn et al. (1963a, b) further developed this important principle of comparing in vivo with in vitro procedures and obtained a good correlation.
Consideration of the available published evidence reveals that at present there is no single ideal preservative for ophthalmic preparations (Brown & Norton 1965 ). The capacity of strains of Ps. aeruginosa or closely related species to become resistant to quaternary ammonium compounds (Riegelman et al. 1956 ), chlorbutol (Lawrence 1955) and phenylethyl alcohol (Murphy et al. 1955 ) and even to decompose phenol (Davy & Turner 1961) and p-hydroxybenzoates (Hugo & Foster 1964) would suggest caution in accepting any new agent supposed to be effective against this enigmatic organism. Many of the reports in the literature are conflicting. Some of the discrepancies may be accounted for by reason of variation in such important factors as reaction temperature, composition of reaction mixture and recovery medium. Importance must be attached to the results of those workers who have clearly defined their experimental conditions, and who have related the efficiency of the inactivators used in their recovery media to the results of in vivo tests. The capacity or not to cause disease appears to be the ultimate, objective assessment, particularly when activity is measured in a final ophthalmic formulation. While a concentration-of about 0-1% mixture may be effective in some eye preparations, the capacity of Ps. aeruginosa to utilize (Hugo & Foster 1964 ) these compounds as a source of carbon would seem to preclude their recommendation for widespread use. The available evidence suggests that the concentration used in Solution for Eye Drops BPC (00229% methyl, 0-0114% propyl) is unlikely to sterilize, and may possibly allow growth ofPs. aeruginosa.
Chlorocresol: The small amount of available evidence supports the use of chlorocresol 0-05 % for the use with intact, but not damaged, eyes.
Chlorbutol: The considerable volume of work on chlorbutol has shown that almost all workers have found it to be consistently an effective but relatively slow sterilizing agent. It would seem that formulation aspects of this agent have been adequately investigated (Murphy et al. 1955 , Schradie & Miller 1959 .
Organic mercurials: The mercurials have been shown to be effective sterilizing agents by nearly all workers. Riegelman et al. (1956) found 0-0l % phenylmercuric nitrate (PMN) required longer than a week to sterilize a heavy inoculum of Ps. aeruginosa, but Kohn et al. (1963a) , using several strains and similar procedures to those of Riegelman and his co-workers, found that sterilization was effected in six hours. It has been shown that these mercurials may give rise to 'mercurialentis' and that mercury may deposit on the lens capsule. There is little published evidence about this condition. Ridley (1958) found very few cases of dermatitis medicamentosa with PMN preservation. They occurred only when the drops were used for a long period and in every case the reaction was slight. Burn (1962) reported a study of mercurialentis among workers in a thermometer factory and found '... that all those regularly handling mercury in the course of their work develop mercurialentis within a year or two'. He found that mercurialentis itself did not cause any damage to sight but there was evidence that other abnormalities were possible with these mercury workers. Abrams' work suggests that the condition is probably innocuous and may not occur with all mercurial compounds (Abrams 1963 , Abrams et al. 1965 .
Work is in progress in our laboratory to elucidatethis situation. Rabbits' eyes have been irrigated with mercurial solution, subsequently sectioned, and examined with an electron probe microanalyser. It is hoped that these procedures and others using activation analysis will provide useful information about local concentrations of mercury.
Phenylethyl alcohol: The available evidence offers little support for the use of phenylethyl alcohol as an ophthalmic preservative.
Benzalkonium chloride: The evidence about quaternary ammonium compounds is clouded by numerous quotations of opinions, assertions unsupported by data and even errors in quoting the literature . A literature search has revealed very few instances where resistance to benzalkonium chloride has been demonstrated; Murphy et al. (1955) and Riegelman et al. (1956) have shown the existence of highly resistant strains of Ps. aeruginosa. On the other hand, it has been shown that faulty procedures may enable contaminants to acquire resistance, particularly to quaternary ammonium compounds (Lowbury 1951) . The available evidence supports the conclusion of Riegelman & Vaughan (1958) : 'With all its limitations, benzalkonium chloride is among the most effective and rapidly acting preservatives when the conditions of its use are properly controlled.' Polymyxin B sulphate: There is no evidence of resistance by Ps. aeruginosa to polymyxin B sulphate. This antibiotic is limited by its relatively low activity against Gram-positive organisms, and some species of Proteus (Wiggins 1952) . The USNF XI suggests the use of a combination of 1,000 units/ml polymyxin B sulphate and 0-01 % benzalkonium chloride. New compounds: The newly recommended ophthalmic preservatives include several promising compounds but more work needs to be done on them before they can be accepted. Chlorhexidine is an exception in that it has been introduced into the Australian Pharmaceutical Formulary and experience in practice has been gained. Nevertheless there are problems of compatibility with this compound and it is not uniformly satisfactory with all ophthalmic solutions (Anderson 1964) .
Conclusions
When suitably formulated, the following compounds have reasonable scientific support for their use as ophthalmic preservatives in appropriate cases: 005 % chlorocresol, 05% chlorbutol, 0-01 % benzalkonium chloride, 0 005 % chlorhexidine, phenylmercuric salts and thiomersalate.
Little attention has been paid to the use of combinations of agents. The recommendation of a combination of polymyxin B sulphate and benzalkonium chloride by USNF XI would seem to be based on attaining broad-spectrum activity rather than an expectation of synergism against any particular organism. Attention has been drawn to the dangers of indiscriminately combining antimicrobial agents (Garrett 1958 , Jawetz & Gunnison 1953 . Preliminary work has shown synergism between phenylethyl alcohol and the organic mercurials (Hugo & Foster 1963) .
The future appears to lie more in the understanding of the nature of the resistance of Ps. aeruginosa to chemical inactivation than in the discovering of other new agents. The literature possesses several monuments to the capacity of this beast literally to eat the agents used against it.
We have shown in our own laboratory (Brown & Richards 1965 ) that the resistance of this organism to several agents is drastically reduced in the presence of ethylenediamine tetracetic acid. Also we have shown that cells grown in the presence of Tween 80 are much less resistant to the action of several agents than are cells grown in plain broth (Brown & Richards 1964) . It has been suggested that the resistance ofPs. aeruginosa is connected with its slime production and its membrane permeability both of which may be affected by Tween 80.
The problems of sterilization and preservation have for too long been overshadowed by considerations of tonicity and the attendant calculations now shown to be largely unnecessary. The time seems appropriate, and even overdue, to adjust long-held ideas relating to ophthalmic formulations. The inadequate use made of pharmaceutical advances has recently been discussed .
From the point of view of the physician, the Mrs Beeton approach to prescribing ophthalmic solutions must be abandoned. Adding a 'dash' of Tween 80, a 'pinch' of methylcellulose and a'drop' of chlorhexidine to solutions at random may well result in a very indigestible stew indeed.
